Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. Drugs used in
chemotherapy use different ways to stop cancer cells from dividing so they stop growing or
die. Combining chemotherapy with donor peripheral stem cell transplantation may allow the
doctor to give higher doses of chemotherapy drugs and kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining total-body irradiation with
fludarabine and donor peripheral stem cell transplantation in treating patients who have
hematologic cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Simmons Cancer Center University of Texas Southwestern Medical Center